en
Scientific article
English

Combined radioimmunotherapy and radiotherapy of liver metastases from colorectal cancer: a feasibility study

Published inAnticancer research, vol. 20, no. 3B, p. 1889-1896
Publication date2000
Abstract

A combination of radioimmunotherapy (RIT) and radiotherapy (RT) should allow one to increase the dose of radiation targeting a particular tumour without the concomitant increase of toxic side effects. This might be obtained if the dose limiting side effect of each individual radiation therapy concerned different organs.

Keywords
  • Adult
  • Animals
  • Antibodies, Monoclonal/adverse effects/pharmacokinetics/therapeutic use
  • Bone Marrow Diseases/etiology
  • Carcinoembryonic Antigen/immunology
  • Colorectal Neoplasms/pathology
  • Combined Modality Therapy
  • Dose Fractionation
  • Drug Administration Schedule
  • Feasibility Studies
  • Female
  • Humans
  • Immunoglobulin Fab Fragments/adverse effects/therapeutic use
  • Iodine Radioisotopes/adverse effects/pharmacokinetics/therapeutic use
  • Liver Diseases/etiology
  • Liver Function Tests
  • Liver Neoplasms/radiotherapy/secondary/therapy
  • Male
  • Mice
  • Mice, Nude
  • Middle Aged
  • Premedication
  • Radioimmunotherapy/adverse effects
  • Radiotherapy Dosage
  • Radiotherapy, High-Energy/adverse effects
  • Tissue Distribution
  • Treatment Outcome
Citation (ISO format)
BUCHEGGER, Franz et al. Combined radioimmunotherapy and radiotherapy of liver metastases from colorectal cancer: a feasibility study. In: Anticancer research, 2000, vol. 20, n° 3B, p. 1889–1896.
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0250-7005
492views
1downloads

Technical informations

Creation03/24/2015 4:11:00 PM
First validation03/24/2015 4:11:00 PM
Update time03/14/2023 11:03:44 PM
Status update03/14/2023 11:03:44 PM
Last indexation08/29/2023 3:25:44 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack